JP2015504438A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504438A5 JP2015504438A5 JP2014542858A JP2014542858A JP2015504438A5 JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5 JP 2014542858 A JP2014542858 A JP 2014542858A JP 2014542858 A JP2014542858 A JP 2014542858A JP 2015504438 A5 JP2015504438 A5 JP 2015504438A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- use according
- composition
- administered
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11190826.5 | 2011-11-25 | ||
| EP11190826.5A EP2596806A1 (en) | 2011-11-25 | 2011-11-25 | Method for prevention of colectomy |
| US201261595230P | 2012-02-06 | 2012-02-06 | |
| US61/595,230 | 2012-02-06 | ||
| PCT/EP2012/073501 WO2013076262A1 (en) | 2011-11-25 | 2012-11-23 | Method for prevention of colectomy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Division JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504438A JP2015504438A (ja) | 2015-02-12 |
| JP2015504438A5 true JP2015504438A5 (enExample) | 2016-01-28 |
| JP6193248B2 JP6193248B2 (ja) | 2017-09-06 |
Family
ID=45094516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014542858A Expired - Fee Related JP6193248B2 (ja) | 2011-11-25 | 2012-11-23 | 結腸切除の予防のための方法 |
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016218270A Expired - Fee Related JP6318221B2 (ja) | 2011-11-25 | 2016-11-08 | 結腸切除の予防のための方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9492516B2 (enExample) |
| EP (3) | EP2596806A1 (enExample) |
| JP (2) | JP6193248B2 (enExample) |
| CA (1) | CA2892203C (enExample) |
| CY (1) | CY1122089T1 (enExample) |
| DK (1) | DK2782602T3 (enExample) |
| ES (1) | ES2745677T3 (enExample) |
| HR (1) | HRP20191723T1 (enExample) |
| HU (1) | HUE046154T2 (enExample) |
| LT (1) | LT2782602T (enExample) |
| PL (1) | PL2782602T3 (enExample) |
| PT (1) | PT2782602T (enExample) |
| RS (1) | RS59358B1 (enExample) |
| SI (1) | SI2782602T1 (enExample) |
| SM (1) | SMT201900527T1 (enExample) |
| WO (1) | WO2013076262A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881808C (en) * | 2013-07-05 | 2021-08-17 | Sony Corporation | Transmission apparatus, transmission method, reception apparatus, and reception method |
| CN110177544A (zh) | 2016-11-29 | 2019-08-27 | 普尔泰克健康有限公司 | 用于递送治疗剂的外泌体 |
| CN110770345A (zh) | 2017-04-14 | 2020-02-07 | 托尔奈公司 | 免疫调节多核苷酸、抗体缀合物及其使用方法 |
| GB201707503D0 (en) | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New Therapy 3 |
| GB201707501D0 (en) * | 2017-05-10 | 2017-06-21 | Index Pharmaceuticals Ab | New therapy 2 |
| GB201807312D0 (en) * | 2018-05-03 | 2018-06-20 | Index Pharmaceuticals Ab | Formulation |
| GB201818579D0 (en) * | 2018-11-14 | 2018-12-26 | Index Pharmaceuticals Ab | New therapy |
| GB201912191D0 (en) * | 2019-08-24 | 2019-10-09 | Index Pharmaceuticals Ab | New therapy |
| EP4147688A1 (en) * | 2021-09-09 | 2023-03-15 | InDex Pharmaceuticals AB | Enema formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| US5849719A (en) | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
| ES2366201T3 (es) | 1994-07-15 | 2011-10-18 | University Of Iowa Research Foundation | Oligonucleótidos inmunmoduladores. |
| EP0879284B1 (en) | 1996-01-30 | 2009-07-29 | The Regents of The University of California | Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| CA2268825C (en) | 1996-10-11 | 2006-04-18 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6426334B1 (en) | 1997-04-30 | 2002-07-30 | Hybridon, Inc. | Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal |
| CA2301575C (en) | 1997-05-20 | 2003-12-23 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
| US6809193B2 (en) * | 1997-08-13 | 2004-10-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| US7914990B2 (en) | 2005-01-13 | 2011-03-29 | Progenika Biopharma, S.A. | Methods and products for in vitro genotyping |
| US20090143319A1 (en) | 2005-06-06 | 2009-06-04 | Angesmg, Inc. | Transcription factor decoy |
| SI2179737T1 (sl) | 2005-07-01 | 2014-02-28 | Index Pharmaceuticals Ab | Modulacija reakcije na stereoide |
| ATE476193T1 (de) * | 2005-07-01 | 2010-08-15 | Index Pharmaceuticals Ab | Immunstimulatorisches verfahren |
| CA2778961C (en) * | 2008-11-04 | 2019-06-18 | Index Pharmaceuticals Ab | Compounds and methods for the treatment of inflammatory diseases of the cns |
-
2011
- 2011-11-25 EP EP11190826.5A patent/EP2596806A1/en not_active Withdrawn
-
2012
- 2012-11-23 DK DK12790904.2T patent/DK2782602T3/da active
- 2012-11-23 US US14/359,945 patent/US9492516B2/en not_active Expired - Fee Related
- 2012-11-23 CA CA2892203A patent/CA2892203C/en active Active
- 2012-11-23 SI SI201231671T patent/SI2782602T1/sl unknown
- 2012-11-23 SM SM20190527T patent/SMT201900527T1/it unknown
- 2012-11-23 JP JP2014542858A patent/JP6193248B2/ja not_active Expired - Fee Related
- 2012-11-23 HR HRP20191723 patent/HRP20191723T1/hr unknown
- 2012-11-23 EP EP12790904.2A patent/EP2782602B1/en active Active
- 2012-11-23 HU HUE12790904A patent/HUE046154T2/hu unknown
- 2012-11-23 PL PL12790904T patent/PL2782602T3/pl unknown
- 2012-11-23 RS RSP20191190 patent/RS59358B1/sr unknown
- 2012-11-23 ES ES12790904T patent/ES2745677T3/es active Active
- 2012-11-23 EP EP19173912.7A patent/EP3556403A1/en not_active Withdrawn
- 2012-11-23 LT LTEP12790904.2T patent/LT2782602T/lt unknown
- 2012-11-23 PT PT127909042T patent/PT2782602T/pt unknown
- 2012-11-23 WO PCT/EP2012/073501 patent/WO2013076262A1/en not_active Ceased
-
2016
- 2016-09-14 US US15/264,709 patent/US9795627B2/en not_active Expired - Fee Related
- 2016-11-08 JP JP2016218270A patent/JP6318221B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-21 US US15/711,228 patent/US20180015117A1/en not_active Abandoned
-
2019
- 2019-09-26 CY CY20191101013T patent/CY1122089T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504438A5 (enExample) | ||
| HRP20191723T1 (hr) | Nukleotid dims0-150 za primjenu u liječenju kroničnog aktivnog ulceroznog kolitisa | |
| JP2016074736A5 (enExample) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2015514418A5 (enExample) | ||
| IL317818A (en) | Oligonucleotides to reduce PD-L1 expression | |
| JP2014513954A5 (enExample) | ||
| JP2016195616A5 (enExample) | ||
| JP2018110601A5 (enExample) | ||
| JP2017505623A5 (enExample) | ||
| JP2014532704A5 (enExample) | ||
| MX363023B (es) | Formulaciones orales de analogos de citidina y metodos para usar los mismos. | |
| JP2013067645A5 (enExample) | ||
| JP2011225596A5 (enExample) | ||
| ME02321B (me) | Antivirusna jedinjenja | |
| JP2013518107A5 (enExample) | ||
| JP2016508134A5 (enExample) | ||
| MX359548B (es) | Agentes de iarn modificados. | |
| JP2015514778A5 (enExample) | ||
| JP2020522244A5 (enExample) | ||
| JP2017521433A5 (enExample) | ||
| PH12014500965A1 (en) | Methods for treating cancers using oral formulations of cytidine analogs | |
| AR084319A1 (es) | INHIBIDORES DE microARN (miARN O miR) QUE COMPRENDEN NUCLEOTIDOS BLOQUEADOS | |
| FI3166615T3 (fi) | Kelatoituja fosforotioaattinukleiinihappopolymeerejä käytettäväksi yhdistelmänä HBV-polymeraasin inhibiittorin kanssa hepatiitti B- ja hepatiitti D -virusinfektioiden hoitamiseksi | |
| JP2015511821A5 (enExample) |